Strikingly, genetic ablation of PTPRZ1 unleashed a profound suppression of tumor growth, with KO tumors exhibiting a dramatic ≈70% reduction in volume compared to controls by day 37 post‐implantation (Figure 5A,B, P < 0.01). This evidence concerns the gene PTPRZ1 and neoplasm.